Page last updated: 2024-11-02

pindolol and Adenocarcinoma

pindolol has been researched along with Adenocarcinoma in 2 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
"Imipramine binding sites were absent."1.27Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors. ( Lange, F; Lange, J; Morin, D; Tillement, JP; Zini, R, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, PG1
Merryman, J1
Orloff, M1
Schuller, HM1
Morin, D1
Zini, R1
Lange, F1
Lange, J1
Tillement, JP1

Other Studies

2 other studies available for pindolol and Adenocarcinoma

ArticleYear
Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease.
    Cancer research, 1995, Aug-15, Volume: 55, Issue:16

    Topics: Adenocarcinoma; Cell Division; Colforsin; Cyclic AMP; Epinephrine; Humans; In Vitro Techniques; Iodo

1995
Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors.
    International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:11

    Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Humans; Imipramine; In Vitro

1987